Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Piccin · SciRah

Researcher profile · Semantic Scholar

L. Piccin

Share profile

L. Piccin — researcher profile on SciRah

h-index: 10
Works: 44
Citations: 498

Most-cited papers

Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
S. Valpione, S. Pasquali, L. Campana, L. Piccin +3 more
2018Journal of Translational Medicine184 citations Open access
Semantic Scholar
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
P. Ascierto, M. Casula, J. Bulgarelli, M. Pisano +33 more
2024Nature Communications95 citations Open access
Semantic Scholar
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer
Sara Pellegrino, R. Fonti, E. Mazziotti, L. Piccin +5 more
2019Annals of Nuclear Medicine49 citations
Semantic Scholar
A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance
M. Scaini, C. Catoni, C. Poggiana, J. Pigozzo +13 more
2024npj Precision Oncology25 citations Open access
Semantic Scholar
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review
I. Cosci, V. Salizzato, P. Del Fiore, J. Pigozzo +6 more
2025Pharmaceuticals22 citations Open access
Semantic Scholar
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.
P. Ascierto, Mario Mandalá, P. F. Ferrucci, M. Guidoboni +33 more
2024NEJM Evidence17 citations Open access
Semantic Scholar
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
M. Ottaviano, M. Curvietto, P. Rescigno, M. Tortora +91 more
2020Journal for ImmunoTherapy of Cancer14 citations Open access
Semantic Scholar
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients
G. Pasello, A. Fabricio, P. Del Bianco, V. Salizzato +14 more
2024Journal of Translational Medicine13 citations Open access
Semantic Scholar
Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations
Elia Cappelletto, L. T. Fasiolo, V. Salizzato, L. Piccin +7 more
2024International Journal of Biological Markers10 citations Open access
Semantic Scholar
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features
P. Del Fiore, Francesco Cavallin, Marcodomenico Mazza, C. Benna +18 more
2022Environmental Health10 citations Open access
Semantic Scholar
Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143)
M. Rastrelli, P. Del Fiore, I. Russo, J. Tartaglia +29 more
2021Frontiers in Oncology9 citations Open access
Semantic Scholar
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants
M. Scaini, L. Piccin, Davide Bassani, A. Scapinello +10 more
2023International Journal of Molecular Sciences8 citations Open access
Semantic Scholar
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade
S. Valpione, S. Pasquali, L. Campana, L. Piccin +3 more
2018Journal of Translational Medicine7 citations Open access
Semantic Scholar
Polygenic Risk Score Improves Melanoma Risk Assessment in a Patient Cohort from the Veneto Region of Italy
S. Pellegrini, T. Potjer, P. Del Bianco, A. Vecchiato +8 more
2024Biology5 citations Open access
Semantic Scholar
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach
C. Catoni, C. Poggiana, A. Facchinetti, J. Pigozzo +5 more
2022Cancers5 citations Open access
Semantic Scholar
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC).
G. Pasello, A. S. Fabricio, P. Del Bianco, A. Favaretto +14 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
Germ cell tumors in male patients without gonadal involvement: computed tomography/magnetic resonance imaging findings and diagnostic workflow.
S. Dell'Aversana, M. Coppola, V. Romeo, L. Ugga +9 more
2019Quantitative Imaging in Medicine and Surgery4 citations Open access
Semantic Scholar
Predictors of toxicity for metastatic melanoma patients treated with ipilimumab
S. Valpione, S. Pasquali, L. Campana, S. Mocellin +3 more
2015Journal of Immunotherapy for Cancer4 citations Open access
Semantic Scholar
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions
R. Cappellesso, L. Nicolè, P. Del Fiore, L. Barzon +17 more
2022International Journal of Molecular Sciences3 citations Open access
Semantic Scholar
RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study
L. Nicolè, Filippo Cappello, R. Cappellesso, L. Piccin +7 more
2021Frontiers in Oncology3 citations Open access
Semantic Scholar
Serum thymidine kinase activity (TKa) as a potential biomarker in the sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma (SECOMBIT) trial.
H. Helgadottir, M. Capone, Claudia Piccinini, L. Piccin +16 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
Tebentafusp in metastatic uveal melanoma patients: Results of the Italian expanded access program.
E. Rossi, L. Di Guardo, E. Simeone, D. Giannarelli +16 more
2025Journal of Clinical Oncology2 citations
Semantic Scholar
A model workflow for microfluidic enrichment and genetic analysis of circulating melanoma cells
C. Poggiana, A. Piazza, C. Catoni, Ilaria Gallingani +13 more
2025Scientific Reports2 citations Open access
Semantic Scholar
Immunohistochemical and molecular profiling of uveal melanoma: clinicopathological correlations from an Italian cohort
F. Fortarezza, G. Zarrilli, G. Munari, Valentina Angerilli +11 more
2025Pathologica1 citations Open access
Semantic Scholar
Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: a retrospective EUMelaReg multicenter study
E. Ellebaek, M. Weichenthal, I. Gavrilova, N. Asher +45 more
2025EJC Skin Cancer1 citations Open access
Semantic Scholar
Identifying High-Risk Features and Improving Follow-Up Strategies in Thin Melanoma: A Retrospective Cohort Study.
A. Vecchiato, C. Cozzolino, P. Del Fiore, F. Cassalia +11 more
2025Clincal and Experimental Dermatology1 citations
Semantic Scholar
Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel)
A. Pavan, L. Calvetti, A. Dal Maso, A. Fabozzi +7 more
2019Annals of Oncology1 citations Open access
Semantic Scholar
Clinicopathologic Features and Treatment Outcomes of Squamoid Eccrine Ductal Carcinoma: A Comprehensive Retrospective Series.
F. Fortarezza, L. Gnesotto, P. Del Fiore, S. Tropea +12 more
2026American journal of dermatopathology0 citations Open access
Semantic Scholar
Melanomas confined to the lung: Integrated clinicopathological and molecular assessment of a case series.
F. Fortarezza, F. Pezzuto, P. Del Fiore, Gerardo Cazzato +7 more
2026Annals of Diagnostic Pathology0 citations
Semantic Scholar
Erratum to “Efficacy of combined BRAF-MEK inhibitor second-line therapy in patients with non-resectable or metastatic BRAFV600-positive melanoma after prior immunotherapy: A retrospective EUMelaReg multicenter study” [EJC Skin Cancer 4 (2026) 100773]
E. Ellebaek, M. Weichenthal, I. Gavrilova, N. Asher +45 more
2026EJC Skin Cancer0 citations Open access
Semantic Scholar
New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma
A. Spagnoletti, L. Di Guardo, A. Indini, M. Di Nicola +11 more
2026Cancers0 citations Open access
Semantic Scholar
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma
Nikolaos Papadopoulos, M. Del Vecchio, A. Spagnoletti, J. Pigozzo +6 more
2026Cancers0 citations Open access
Semantic Scholar
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions
F. Pravisano, Jacopo Costa, L. De Marchi, G. Pascoletti +12 more
2026Cancers0 citations Open access
Semantic Scholar
Circulating Thymidine Kinase Activity Predicts Survival and Optimal Treatment Sequencing in BRAF-Mutated Metastatic Melanoma in the SECOMBIT Trial
H. Helgadottir, M. Capone, L. Ridolfi, A. Zambelli +23 more
2026Clinical Cancer Research0 citations Open access
Semantic Scholar
A functional precision medicine strategy to guide patient selection for oncolytic vaccination in NRAS -mutant melanoma.
L. Piccin, Sara Mathlouthi, V. Salizzato, P. Del Fiore +6 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?
L. Piccin, V. Guarneri, M. Del Vecchio, A. Spagnoletti +7 more
2026Cancers0 citations Open access
Semantic Scholar
BRAF/MEK inhibitor rechallenge in patients with non-resectable or metastatic BRAF V600-mutated melanoma: a stratified, controlled, retrospective EUMelaReg multicenter study
M. Weichenthal, I. Gavrilova, Peter Mohr, B. Özdemir +27 more
2026EJC Skin Cancer0 citations Open access
Semantic Scholar
Decoding microRNA transcriptome in Merkel cell carcinoma to define new prognostic signatures
L. Nicolé, R. Cappellesso, A. Giannella, L. Piccin +5 more
2025EJC Skin Cancer0 citations Open access
Semantic Scholar
528 A novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution identified predictive spatial biomarkers in immunotherapy- and targeted therapy-treated melanoma patients
Antonio Sorrentino, E. Markovits, Marion Bonnet, M. Mints +18 more
2025Regular and Young Investigator Award Abstracts0 citations Open access
Semantic Scholar
Application of a novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution for predictive spatial biomarker identification on immunotherapy-treated melanoma patients.
P. Ascierto, Marion Bonnet, Pedro Machado Almeida, G. Madonna +16 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
[Amelanotic acral melanoma originating from the foot: a clinical case.]
L. Piccin
2021Recenti progressi in medicina0 citations
Semantic Scholar
Correlates of toxicity in metastatic melanoma patients treated with ipilimumab.
S. Valpione, J. Pigozzo, S. Pasquali, L. Piccin +3 more
20160 citations
Semantic Scholar
1098PPREDICTORS OF SURVIVAL FOR THERAPY WITH IPILIMUMAB IN METASTATIC MELANOMA.
S. Valpione, Marco Bazzi, L. Piccin, J. Pigozzo +1 more
2014Annals of Oncology0 citations Open access
Semantic Scholar
EPIDEMIOLOGY, GENETICS AND PATHOGENESIS Impact of partIculate matter exposure on melanoma rIsk: a multIcentre case-control study
F. Bellinato, G. Adami, M. A. Reatini, G. Cattani +68 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Pigozzo×25
Invite
J. Pigozzo — researcher profile on SciRah
V. Chiarion-Sileni×18
Invite
V. Chiarion-Sileni — researcher profile on SciRah
P. Del Fiore×12
Invite
P. Del Fiore — researcher profile on SciRah
A. Fabozzi×10
Invite
A. Fabozzi — researcher profile on SciRah

×8

Invite

M. Del Vecchio — researcher profile on SciRah

V. Salizzato×8

Invite

V. Salizzato — researcher profile on SciRah

A. D. Dei Tos×7

Invite

A. D. Dei Tos — researcher profile on SciRah

Invite

S. Mocellin — researcher profile on SciRah

Invite

A. Arance — researcher profile on SciRah

Michele Guida×6

Invite

Michele Guida — researcher profile on SciRah

D. Giannarelli×6

Invite

D. Giannarelli — researcher profile on SciRah

Simone Mocellin×6

Invite

Simone Mocellin — researcher profile on SciRah